Bioforce Nanosciences Holdings, Inc. Liquidation Value Calculator
Bioforce Nanosciences Holdings, Inc.
Current Price: N/A
Loading calculator data...
Advanced: All 36 XBRL Tags
Every XBRL tag from SEC EDGAR filings, grouped by financial statement type. total = may include children, fact = independent leaf value.
Balance Sheet
| Tag | Value | Unit | ||
|---|---|---|---|---|
| cash | ||||
| Cash And Cash Equivalents At Carrying Value total CashAndCashEquivalentsAtCarryingValue |
$786 | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents total CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
$786 | USD | ||
| liabilities_current | ||||
| Liabilities Current total LiabilitiesCurrent |
$619,329 | USD | ||
| liabilities_total | ||||
| Liabilities total | $619,329 | USD | ||
| shares_outstanding | ||||
| Common Stock Shares Outstanding total CommonStockSharesOutstanding |
33.5M | shares | ||
Unmapped Tags (29)
| Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent | $11,836 | USD | ||
| Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock | $161.76M | USD | ||
| Assets Assets | $786 | USD | ||
| Assets Current AssetsCurrent | $786 | USD | ||
| Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Common Stock Shares Authorized CommonStockSharesAuthorized | $900.00M | shares | ||
| Common Stock Shares Issued CommonStockSharesIssued | $33.52M | shares | ||
| Common Stock Value CommonStockValue | $33,522 | USD | ||
| Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt | $802,000 | USD | ||
| Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity | $786 | USD | ||
| Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Preferred Stock Shares Authorized PreferredStockSharesAuthorized | $100.00M | shares | ||
| Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit | $-162.41M | USD | ||
| Stockholders Equity StockholdersEquity | $-618,543 | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | $-76 | USD | ||
| Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | $3,000 | USD | ||
| Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries | $421,801 | USD | ||
| Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities | $65,074 | USD | ||
| Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities | $-65,150 | USD | ||
| Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt | $65,074 | USD | ||
| Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold | $423,000 | USD | ||
| Earnings Per Share Basic EarningsPerShareBasic | $-0 | USD/shares | ||
| Earnings Per Share Diluted EarningsPerShareDiluted | $-0 | USD/shares | ||
| General And Administrative Expense GeneralAndAdministrativeExpense | $66,951 | USD | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | $-489,951 | USD | ||
| Net Income Loss NetIncomeLoss | $-1.29M | USD | ||
| Operating Expenses OperatingExpenses | $489,951 | USD | ||
| Other Expenses OtherExpenses | $4,075 | USD | ||
| Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent | $506,203 | USD |
Showing balance sheet tags only. Liquidation analysis uses balance sheet data.